Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1997 Oct;73(5):331–332. doi: 10.1136/sti.73.5.331

Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the western Pacific.

A Moss
PMCID: PMC1195885  PMID: 9534737

Full text

PDF
332

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bogaerts J., Tello W. M., Akingeneye J., Mukantabana V., Van Dyck E., Piot P. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin Med. 1993 Jun;69(3):196–200. doi: 10.1136/sti.69.3.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Catchpole M. A. The role of epidemiology and surveillance systems in the control of sexually transmitted diseases. Genitourin Med. 1996 Oct;72(5):321–329. doi: 10.1136/sti.72.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Deguchi T., Saito I., Tanaka M., Sato K., Deguchi K., Yasuda M., Nakano M., Nishino Y., Kanematsu E., Ozeki S. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones. Sex Transm Dis. 1997 May;24(5):247–250. doi: 10.1097/00007435-199705000-00002. [DOI] [PubMed] [Google Scholar]
  4. Fox K. K., Knapp J. S., Holmes K. K., Hook E. W., 3rd, Judson F. N., Thompson S. E., Washington J. A., Whittington W. L. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis. 1997 Jun;175(6):1396–1403. doi: 10.1086/516472. [DOI] [PubMed] [Google Scholar]
  5. From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994. JAMA. 1994 Jun 8;271(22):1733–1734. [PubMed] [Google Scholar]
  6. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  7. Kam K. M., Lo K. K., Ho N. K., Cheung M. M. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourin Med. 1995 Jun;71(3):141–144. doi: 10.1136/sti.71.3.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Knapp J. S., Mesola V. P., Neal S. W., Wi T. E., Tuazon C., Manalastas R., Perine P. L., Whittington W. L. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines. Sex Transm Dis. 1997 Jan;24(1):2–7. doi: 10.1097/00007435-199701000-00002. [DOI] [PubMed] [Google Scholar]
  9. Knapp J. S., Wongba C., Limpakarnjanarat K., Young N. L., Parekh M. C., Neal S. W., Buatiang A., Chitwarakorn A., Mastro T. D. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Sex Transm Dis. 1997 Mar;24(3):142–148. doi: 10.1097/00007435-199703000-00004. [DOI] [PubMed] [Google Scholar]
  10. Tanaka M., Kumazawa J., Matsumoto T., Kobayashi I. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin Med. 1994 Apr;70(2):90–93. doi: 10.1136/sti.70.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES